Investigator's Brochure (IB) Table

Vaccines

Vaccine Name Sort descending Vaccine Company IB Date Risk List Available?
10-1074 Rockefeller University/Mass Biologics September 2020
10-1074-LS Rockefeller University October 2021
3BNC117-LS - New Rockefeller University October 2021
426c.Mod.Core-C4b, Adjuvanted - New DAIDS/NIAID/NIH February 2022
Ad26.ENVA.01 Crucell Holland BV June 2013
AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE Vaccines DAIDS/NIAID/NIH March 2021
AIDSVAX B/E Global Solutions for Infectious Diseases March 2016
ALVAC-HIV (vCP2438) Sanofi Pasteur August 2017
BG505 SOSIP.664 gp140 DAIDS/NIAID/NIH October 2019
Bivalent Subtype C gp120/MF59 and Bivalent Subtype C gp120/AS01B GlaxoSmithKline July 2016
CH505 TF chTrimer DAIDS/NIAID/NIH November 2020
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
CMV-MVA Triplex City of Hope National Medical Center March 2020
EnvSeq-1 and EnvSeq-2 DAIDS/NIAID/NIH June 2021
GLA-SE Infectious Disease Research Institute (IDRI) November 2021
Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) Dynavax Technologies Corporation September 2021
HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA Profectus BioSciences August 2018
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
mRNA-1273 ModernaTX December 2020
mRNA-1574 Trimer Vaccines DAIDS/NIAID/NIH October 2021